RYAN CASEY: Open Payments
NPI 1043695463 · DINUBA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 25 payments from 11 companies in 2025. Trend: 2023 $1,595 · 2024 $1,806 · 2025 $675
Food & beverage: $575Education: $100
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 7 | $173 |
| SEAGEN INC. | 1 | $100 |
| Verity Pharmaceuticals Inc. | 3 | $80 |
| Antares Pharma, Inc. | 2 | $62 |
| Dendreon Pharmaceuticals LLC | 2 | $57 |
| PFIZER INC. | 3 | $47 |
| ConvaTec Inc. | 2 | $42 |
| Sagent Pharmaceuticals | 2 | $41 |
| 180 Medical, Inc. | 1 | $30 |
| Astellas Pharma US Inc | 1 | $23 |
Products named: GEMTESA, Tlando, ORGOVYX, Xtandi, XYOSTED, PROVENGE, GENTLECATH, Glydo.
Industry payments across CA — which companies pay providers there.
